Photobiomodulation and Parkinson

Photobiomodulation in Parkinson´s Disease: A Randomized Controlled Trial.

This study aimed to assess the effects of transcranial photobiomodulation in patients with Parkinson's disease (PD).

Thirty-five patients with idiopathic PD were randomly assigned to a photobiomodulation (n=17, [mean±SD] 72±7 years) or sham group (n=18, 70±8 years) during 9 weeks (2 sessions/week). The primary endpoint was the motor portion of the Movement Disorders Society-United PD Rating Scale. Secondary endpoints were the Scales for Outcomes in PD, static posturography, walking ability (ten-meter walk test [TMWT]) and functional mobility (timed up and go [TUG] test).

Inclusion Criteria:

• Having been diagnosed with idiopathic PD.
• Stage 1-2 on the Hoehn and Yahr Scale.
• Having no neurological condition other than PD.
• Being able to stand for 2 minutes and walk 10 meters without assistance.
• Having no severe dyskinesias or "ON-OFF" phases.

Exclusion Criteria:

- Do not follow inclusion criteria.